Orbit Discovery to attend 3rd GPCR-targeted Drug Discovery Summit

February 20, 2024

Our Business Developer Jordan Palfrey is looking forward to attending the 3rd GPCR-Targeted Drug Discovery Summit in Boston from March 5-7, 2024. Please connect with Jordan if you're interested in discovering GPCR therapeutic peptide hits using Orbit's direct-to-cell high throughput functional screening capabilities. We'd be delighted to learn more and discuss how we can help.

Work With Us
As administrators Sue Staunton and Sandra Mundy manage the business, affairs and property of the Company and its agents and without personal liability.

Orbit Discovery Limited registered in England and Wales no.12850396 Registered office The White Building 1-4 Cumberland PlaceSouthampton SO15 2NP. VAT registration number 359593151’.

‍
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs
Contact Us